Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4
Author(s) -
Ningning Zhang,
Yunpeng Xie,
Yidi Tai,
Yingying Gao,
Wei Guo,
Wendan Yu,
Jia Li,
Feng Xu,
Jiaojiao Hao,
Yue Gao,
Xinrui Zhao,
Yina Liao,
Wei Jiang,
Ge Liu,
Wuguo Deng,
Xiaonan Cui
Publication year - 2016
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000453206
Subject(s) - bufalin , telomerase reverse transcriptase , cancer research , apoptosis , cell growth , cancer , cancer cell , telomerase , chemistry , colorectal cancer , chromatin immunoprecipitation , biology , medicine , gene expression , biochemistry , promoter , gene
Bufalin can induce apoptosis in certain human cancer cell lines, but bufalin has not yet been thoroughly evaluated in colorectal cancer cells. Cleavage and polyadenylation specific factor 4 (CPSF4) and human telomerase reverse transcriptase (hTERT) play important roles in colorectal cancer growth. The aim of this study was to investigate the roles and interactions of bufalin, CPSF4 and hTERT and the effects of bufalin in human colorectal cancer.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom